4//SEC Filing
Monahan Joseph 4
Accession 0001415889-25-002940
CIK 0001557746other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:15 PM ET
Size
18.4 KB
Accession
0001415889-25-002940
Insider Transaction Report
Form 4
Monahan Joseph
Chief Scientific Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-02-01−14,750→ 44,250 total→ Common Stock (14,750 underlying) - Award
Employee Stock Option (Right to Buy)
2025-02-03+293,500→ 293,500 totalExercise: $2.40Exp: 2035-02-02→ Common Stock (293,500 underlying) - Exercise/Conversion
Common Stock
2025-02-01+7,500→ 228,562 total - Exercise/Conversion
Common Stock
2025-02-01+14,750→ 243,312 total - Tax Payment
Common Stock
2025-02-01$2.48/sh−11,317$28,066→ 231,995 total - Exercise/Conversion
Restricted Stock Units
2025-02-01−7,500→ 15,000 total→ Common Stock (7,500 underlying) - Award
Restricted Stock Units
2025-02-03+83,900→ 83,900 total→ Common Stock (83,900 underlying)
Holdings
- 193(indirect: By Spouse)
Common Stock
Footnotes (6)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
- [F3]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2023, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
- [F4]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 1, 2024, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
- [F5]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
- [F6]Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001861790
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:15 PM ET
- Size
- 18.4 KB